Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PHGE
PHGE logo

PHGE Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy BiomX Inc (PHGE) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
0.300
1 Day change
-0.66%
52 Week Range
14.710
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

PHGE is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is extremely low-priced, technically weak overall, and lacks supportive fundamental, news, analyst, or insider momentum. While the RSI suggests it is oversold and the MACD is improving, the broader trend remains bearish and there is no proprietary buy signal to justify an immediate purchase. For an impatient investor who does not want to wait for a better entry, this is still not a strong enough setup to buy now.

Technical Analysis

PHGE is trading at 0.33, slightly above the prior close of 0.319. Technicals are mixed but mostly bearish: RSI_6 is 13.644, which indicates deeply oversold conditions, and the MACD histogram is positive and expanding, showing some short-term momentum improvement. However, the moving averages remain bearish with SMA_200 > SMA_20 > SMA_5, confirming the longer trend is still down. Key levels to watch are support at 0.321 and 0.263, with resistance at 0.415 and 0.509. Overall, the stock looks oversold but not yet technically strong enough for a confident long-term entry.

Positive Catalysts

  • RSI is deeply oversold, which can support a short-term bounce. MACD histogram is above zero and expanding, suggesting momentum is improving. Post-market change was +3.45%, which may reflect some late-session interest. Similar candlestick pattern analysis suggests a possible 5.52% gain over the next month.

Neutral/Negative Catalysts

  • No news in the recent week means there is no fresh catalyst driving the stock. Hedge funds are neutral and insiders are neutral, with no significant trading trends over the last quarter or month. The moving average structure is bearish, indicating the longer-term trend remains weak. No valuation data is available, and financial snapshot data was not usable. No recent congress trading data is available. AI Stock Pick and SwingMax both show no signal today.

Financial Performance

Latest quarter financial data was not available due to an error, so there is no reliable quarter-over-quarter revenue or growth trend to assess. Because the latest quarter season cannot be confirmed from the provided data, there is no basis to view recent financial performance as a positive driver.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so Wall Street sentiment cannot be identified from ratings. Based on the available information, the pros view is limited to an oversold technical setup and mild momentum improvement, while the cons view is stronger due to the bearish moving averages, lack of news, neutral insider/hedge fund activity, and absence of a proprietary buy signal.

Wall Street analysts forecast PHGE stock price to rise
1 Analyst Rating
Wall Street analysts forecast PHGE stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.302
sliders
Low
26
Averages
26
High
26
Current: 0.302
sliders
Low
26
Averages
26
High
26
H.C. Wainwright
Joseph Pantginis
Buy -> Neutral
downgrade
AI Analysis
2026-03-09
Reason
H.C. Wainwright
Joseph Pantginis
Price Target
AI Analysis
2026-03-09
downgrade
Buy -> Neutral
Reason
H.C. Wainwright analyst Joseph Pantginis downgraded BiomX to Neutral from Buy. BiomX has "had a rough time as of late," says the analyst, who notes that both the CEO and Chairman of the Board resigned from the company on March 6, adding "further concern about the potential path forward for the company."
H.C. Wainwright
Joseph Pantginis
Buy
upgrade
$15 -> $26
2025-11-25
Reason
H.C. Wainwright
Joseph Pantginis
Price Target
$15 -> $26
2025-11-25
upgrade
Buy
Reason
H.C. Wainwright analyst Joseph Pantginis adjusted the firm's price target on BiomX to $26 from $15 and keeps a Buy rating on the shares. The adjusted target follows the company's reverse stock split.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for PHGE
Unlock Now

People Also Watch